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Previewsexample, a segment of MMP-12 has
recently been shown to have an antimi-
crobial effect (Houghton et al., 2009).
Currently, the noncatalytic domains of
MMPs are considered as being principally
involved in substrate recognition and
inhibitor binding, but we must now ask
whether these domains can play roles
in other biological processes. Studies
showing noncatalytic roles for MMPs
raise multiple questions for the field. (1)
MMP activity has several control check-
points including a requirement for proteo-
lytic removal of a pro-domain to generate
an active protease. Do the findings by
Gonzalo et al. imply that noncatalytic
functions of MMPs are less potent
because the activation of the enzyme is
no longer a required regulatory check-
point? Or is an extra level of control
provided by other players in these non-
proteolytic events? (2) Development of
MMP inhibitors has largely focused on
blocking proteolysis, but are there
scenarios wherein a different domain of
the MMP regulates a biological function4 Developmental Cell 18, January 19, 2010 ªthat promotes disease progression? How
would this be targeted? (3) Do we need to
reinterpret observations garnered from
MMP null mice? We assume that pheno-
typic manifestations are due to the abla-
tion of the catalytic activity of the MMP
in question, but could the lack of other
domains be contributing to the resultant
phenotypes? Given this scenario, would
it be valuable to compare catalytically
dead MMP knockin mice with the total
nulls?
Gonzalo et al. have added another layer
of complexity to MMP research, but the
field has the tools that will be needed to
address the questions raised by these
new insights and to take MMP research
to new heights.
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Cells remember established patterns of gene expression through rounds of cell division despite dynamic
changes in genomic chromatin structure. Two recent studies inMolecular Cell and Nature Medicine, broadly
impacting on epigenetic gene regulation and disease, address how cells remember and suggest that both
histone methyltransferases and locus specific DNA binding proteins can mark transcribed genes for reacti-
vation after mitosis.The mammalian genome is packaged into
condensed heterochromatin and more
open, or accessible, euchromatin—chro-
matin structures that can determine in
large part what genes may be expressed
and hence the differentiated state of a
specific cell. These patterns of chromatin
structure are established in cells by
proteins that modify histone tails through
methylation, acetylation, and ubiquitina-
tion or that methylate DNA directly at CG
dinucleotides. Such epigenetic modifica-tions are thought to instill cellular memory
so that specific patterns of gene expres-
sion are inherited during repeated rounds
of cell division (Ringrose and Paro, 2007).
Two recent studies from Blobel et al.
(2009), published in Molecular Cell, and
Verdegueretal. (2009), published inNature
Medicine, identify two distinct factors that
may mediate the cell’s ability to maintain
and propagate active epigenetic marks.
During early embryonic development,
cell lineage specification and loss of pluri-potency may be due to the establishment
or maintenance of epigenetic marks—
repressive marks at chromatin domains
not expressed in subsequent derivatives
within the lineage, activating marks at
expressed genes, and bivalent marks at
genes destined to be expressed later
(Bernstein et al., 2006; Azuara et al.,
2006). Once histone modifications are
established on chromatin, they must be
propagated during many cell divisions
despite the dynamic structural changes
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Previewsthat the genome undergoes to allow for
replication and transmission. Indeed,
DNA replication must have access to
the double helix and be able to unwind
the strands. Moreover, during mitosis, the
genome must compact into metaphase
chromosomes that are then unpackaged
in the daughter cells. Recent evidence
points to the direct binding of the Poly-
comb repressive complex 2 (PRC2) to
existing repressive histone H3 lysine 27
methyl (H3K27me) marks as a potential
means of propagating the pattern of
repressive modifications in replicating
DNA (Hansen et al., 2008). This PRC2
binding is mediated by an interaction
between the methylated histone H3 tail
with the WD40 repeat domains of EED
(Margueron et al., 2009), a component
of PRC2 necessary for postgastrulation
development and global H3K27 methyla-
tion. Surprisingly, EED binds to other
Polycomb repressive marks, including
H3K9me3 and H4K20me3, but not to
histone methylation marks like H3K4me3
and H3K36me3, which are associated
with active gene expression. Thus, by
recognizing existing repressive marks,
EED may recruit the PRC2 complex and
the associated EZH2 histonemethyltrans-
ferase to stimulate methyltransferase
activity and create new repressive marks
during DNA replication.
How active epigenetic marks are main-
tained and propagated remains more
mysterious. Recently, two important
papers (Blobel et al., 2009; Verdeguer
et al., 2009) address how active gene
expression patterns may be maintained
during cell division and, more critically,
how the loss of gene expression may
be linked to cell division in a disease
process. Blobel et al. (2009) investigated
the genome-wide localization of MLL
(KMT2A), amammalian Trithorax homolog
that methylates H3K4. In contrast to
a previous report, the authors find MLL
associated with mitotic chromosomes.
Even more surprising was the reshuffling
of MLL during mitosis to a different class
of genes than in interphase nuclei, with
more than a thousand new MLL target
sites found exclusively on mitotic chro-
matin. The promoters of many genes that
are highly transcribed during interphase
are occupied by MLL during mitosis,
even if they are not bound by MLL during
interphase. These data led the authors to
propose that MLL is needed to bookmarkhighly expressed genes such that reacti-
vation after mitosis could progress.
Consistent with this, MLL-deficient cells
delayed reactivation of the genes normally
occupied by MLL during mitosis but
exhibited no change in the reactivation
kinetics of interphase MLL targets, such
as the Hox loci. This mitotic reshuffling
also correlated with the localization of
MLL complex proteins, such as RbBP5,
Ash2L, and Menin, at mitotic chromatin
targets, suggesting that H3K4methylation
occurs at these sites.
Even though MLL is required for timely
reactivation of certain genes after mitosis,
the overall levels of H3K4 methylation do
not appear to be affected in the MLL-
depleted cells. This may reflect the sensi-
tivity of the assays and the fact that MLL2
(KMT2B) localizes to many of the same
genes in interphasenuclei thatMLL recog-
nizes on mitotic chromatin. It is of note
that the WD40 domain protein WDR5 is
a component of multiple MLL complexes
and was initially thought to bind to
H3K4me2. Given the structural similarities
between theWD40 b propeller domains of
WDR5 and EED, it seems attractive to
considerwhetherWDR5providesasimilar
link to propagate H3K4me3 during repli-
cation as EED does for PRC2. However,
WDR5 does not appear to bind H3K4
methylated residues with greater affinity
relative to unmodified lysine, and it has
higher affinity for arginine residues in the
histone H3 tail and in theMLL protein itself
(Trievel and Shilatifard, 2009). Still, the
idea that MLL bookmarks certain loci
during mitosis such that gene expres-
sion can be reactivated appropriately is
appealing in its simplicity. It also begets
more questions regarding the locus spec-
ificity of MLL relocalization and the DNA
binding proteins that may drive this
reshuffling.
One such DNA binding protein that
appears to provide an epigenetic book-
mark for gene expression is HNF-1b.
Mutations in HNF-1b are associated with
renal cystic disease and with maturity
onset diabetes of the young type 5. Previ-
ously, HNF-1b was identified as a tran-
scriptional regulator of many genes asso-
ciated with polycystic kidney disease,
including Pkhd1 and Pkd2. Recent work
from Verdeguer et al. (2009) now shows
that a temporal knockout of HNF-1b in
mice also results in a rapidly progressing
cystic kidney disease if the gene isDevelopmental Celldeleted at a time when renal epithelial
cells are still undergoing rapid cell divi-
sion. However, if HNF-1b is deleted
10 days after birth or later whenmost cells
are quiescent, there is little evidence of
cystic disease. This phenomenon might
simply be explained by the fact that cells
must be dividing in order to promote
cyst development in these mutants.
Although this is surely part of the story,
more intriguing observations also came
to light. If HNF-1b was deleted early,
cysts formed and the expression of Pkd2
was lost, consistent with previous re-
ports of direct transcriptional regulation.
However, if HNF-1b was deleted late in
development, Pkd2 expression was not
affected, suggesting that HNF-1b is not
simply a transactivator of Pkd2. Rather,
HNF-1b must have an epigenetic affect
on initiating Pkd2 expression but is
dispensable once activation is specified.
In a fully developed adult kidney,
ischemia or nephrotoxic injury can kill
proximal tubule cells and promote the
regeneration of new epithelia during a
recovery phase. In vivo fate mapping
studies showed that the regenerated
renal epithelia are derived from existing
epithelia that had survived the initial injury
(Humphreys et al., 2008). Verdeguer et al.
(2009) used this property to test whether
reentry into the cell cycle would impact
epithelial cells lacking HNF-1b. After
ischemia, mice with late-deleted HNF-1b
developed cystic disease in recovering
kidneys. More importantly, active epige-
netic marks at the Pkd2 promoter
decreased and the expression of Pkd2
was lost. These data point to an important
role for HNF-1b in maintaining active
epigenetic marks at the Pkd2 locus during
cell division. This locus specificity func-
tion during mitosis for the maintenance
of active epigeneticmarks or the inhibition
of repressive epigenetic mark accumula-
tion may extend to other genes.
Such bookmarking functions are likely
to be essential for retaining the cellular
memory of any dividing cell. Since their
necessity may only be evident once cell
division is activated, mutations in genes
such as HNF-1b in adults may underlie
a latent form of a disease that requires
a second or even third hit to promote
cell division and manifestation of the
disease phenotype. Understanding how
the targets of such bookmarks are reset
during cell division may lead to new18, January 19, 2010 ª2010 Elsevier Inc. 5
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Previewstreatments of diseases that are impacted
by the loss of epigenetic maintenance.
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RNAi is essential for pericentromeric heterochromatic formation in S. pombe, and although Dcr1, the initiator
protein of this process, has been biochemically well described, its subcellular localization has remained
elusive. In this issue of Developmental Cell, Emmerth et al. now show that Dcr1 is dynamically shuttling
between nucleus and cytoplasm, adding new insight into the subcellular mechanics of RNAi.RNA interference (RNAi) is a mechanism
that uses small RNAs as specificity factors
to regulate gene expression. One of the
best-studied small RNA species is the
class of small interfering RNAs (siRNA).
siRNAs are processed from long dsRNA
molecules by dicer, an evolutionary well-
conserved RNaseIII-like ribonuclease,
containing additional functionalities like
a helicase domain and two RNA binding
domains: PAZ (Piwi Argonaute Zwille)
and dsRBD (double-strand RNA binding
domain). Processed siRNAs are loaded
into a cytoplasmic or a nuclear effector
complex called RNA-induced silencing
complex (RISC) or RNA induced transcrip-
tional silencing complex (RITS) respec-
tively. In these complexes, siRNAs are
bound by an Argonaute protein. Depend-
ing on the homology between siRNA and
target RNA and the type of Argonaute,
the target sequence can be silenced in
two different ways: through posttranscrip-
tional gene silencing (PTGS), which acts
directly on the target RNA itself by target
cleavage or translational inhibition, or
through chromatin dependent gene si-
lencing (CDGS), in which chromatin ofthe chromosomal locus producing the
homologous sequence is remodeled into
a repressive state (Carthew and Son-
theimer, 2009; Moazed, 2009).
An organism that has specialized its
RNAi machinery to a great extent to direct
chromatin modification is Schizosacchar-
omyces pombe (S. pombe). In S. pombe,
the formation of pericentromeric hetero-
chromatin is a layered process in which
first euchromatic histone modifications
are removed, and next, Clr4 methylates
H3K9 that is subsequently bound by
Swi6. Biochemical studies have identified
two distinct complexes that are essential
for this heterochromatin formation. The
Argonaute protein Ago1, the tryptophan
GW-motif-containing protein Tas3, and
the chromodomain protein Chp1 make up
the RITS complex, which physically inter-
acts with outer centromeric repeat tran-
scripts in an siRNA-dependent manner.
The RNA-directed RNA polymerase com-
plex (RDRC), which physically interacts
with RITS and amplifies the siRNA signal,
has three core components: Rdp1
(anRNA-directed RNA polymerase), Cid12
(a polyadenylation polymerase), and thepredicted helicase Hrr1. The interactions
among RITS, RDRC, and the centromeric
repeats are Dcr1 dependent, and Dcr1
itself has been reported to interact with
RDRC (Colmenares et al., 2007; Moazed,
2009; Motamedi et al., 2004; Verdel et al.,
2004). Previous reports based on Dcr1
overexpression studies reported counter-
intuitive cytoplasmic localization (Carmi-
chael et al., 2006). In this issue ofDevelop-
mental Cell, Emmerth and colleagues
readdress the question of the subcellular
Dcr1 localization (Emmerth et al., 2010).
First, live cell imaging was performed on
moderately expressed Dcr1-GFP fusion
protein, revealing a predominantly nuclear
localization. Interestingly, the nuclear
localization was not diffuse, but colocal-
ized with the nuclear pores in granule-like
structures on the inner side of the nuclear
membrane. These structures do not co-
localize with RITS components or with
chromatin, implying that siRNA generation
and target recognition could be physically
separated events. Interestingly in Arabi-
dopsis thaliana (A. thaliana) and in the
animal germline-specific Piwi pathway,
the processing of CDGS-associated
